一般演題２１

[O21-2] 活動性潰瘍性大腸炎に対するグセルクマブ導入療法の早期症状改善：QUASAR第3相導入試験

*前本 篤男¹、 Gary R. Lichtenstein²、Axel Dignass³、David T. Rubin⁴、Shadi Yarandi⁵、Kuan-Hsiang G. Huang⁵、Matthew Germinaro⁵、Ye Miao⁵、Hongyan Zhang⁵、宮崎 由実⁶、Jaroslaw Kierkuś⁷、Ursula Seidler⁸、Jessica R. Allegretti⁹、Brian Bressler¹⁰、Laurent Peyrin-Biroulet¹¹ (1. 札幌東徳洲会病院　IBDセンター、2. University of Pennsylvania, Philadelphia, PA, USA、3. Agaplesion Markus Hospital, Goethe University, Frankfurt, Germany、4. University of Chicago Medicine Inflammatory Bowel Disease Center, Chicago, IL、5. Janssen Research & Development, LLC, Spring House, PA, USA、6. ヤンセンファーマ株式会社メディカルアフェアーズ本部、7. WIP Warsaw IBD Point, Warsaw, Poland、8. Medizinische Hochschule Hannover, Germany、9. Brigham and Women’s Hospital Crohn’s and Colitis Center, Boston, MA, USA、10. University of British Columbia, Vancouver, BC, Canada、11. Nancy University Hospital, Université de Lorraine, Nancy, France)